Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bardou

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|April 25, 2008
Pantoprazole: from drug metabolism to clinical relevanceMarc Bardou, Janet Martin
The New England Journal of Medicine|October 26, 2018
Proton-Pump Inhibitor Prophylaxis in the ICU - Benefits Worth the Risks?Alan Barkun, Marc Bardou
Advances in Experimental Medicine and Biology|July 29, 2010
Antitumoral effects of lipids A, clinical studiesMarc Bardou, Danièle Reisser
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
The increasing need for health-economic assessment in gastrointestinal and liver diseasesMarc Bardou, Janet Martin
Gut|July 13, 2018
Prophylactic angiographic embolisation in high-risk peptic ulcer bleeding after achieved endoscopic control: maximising outcomesRomaric Loffroy, Marc Bardou
Critical Care Medicine|February 22, 2013
Stress ulcer prophylaxis in the ICU: who, when, and how?Marc Bardou, Alan N Barkun
Joint Bone Spine|December 22, 2009
Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor interventionMarc Bardou, Alan N Barkun
Annals of Internal Medicine|December 2, 2009
Aspirin withdrawal in acute peptic ulcer bleeding: are we harming patients?Alan N Barkun, Marc Bardou
Expert Opinion on Drug Safety|April 28, 2015
Safety of medication options for treating pediatric esophagitisMarc Bardou, Kyle J Fortinsky
Alimentary Pharmacology & Therapeutics|December 28, 2019
Editorial: how can we best promote the routine use of scores that are accurate at predicting outcomes in patients with upper gastrointestinal bleeding?Marc Bardou, Alan N Barkun
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Expert Opinion on Drug Metabolism & Toxicology|April 25, 2008
Pantoprazole: from drug metabolism to clinical relevanceMarc Bardou, Janet Martin
The New England Journal of Medicine|October 26, 2018
Proton-Pump Inhibitor Prophylaxis in the ICU - Benefits Worth the Risks?Alan Barkun, Marc Bardou
Advances in Experimental Medicine and Biology|July 29, 2010
Antitumoral effects of lipids A, clinical studiesMarc Bardou, Danièle Reisser
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
The increasing need for health-economic assessment in gastrointestinal and liver diseasesMarc Bardou, Janet Martin
Gut|July 13, 2018
Prophylactic angiographic embolisation in high-risk peptic ulcer bleeding after achieved endoscopic control: maximising outcomesRomaric Loffroy, Marc Bardou
Critical Care Medicine|February 22, 2013
Stress ulcer prophylaxis in the ICU: who, when, and how?Marc Bardou, Alan N Barkun
Joint Bone Spine|December 22, 2009
Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor interventionMarc Bardou, Alan N Barkun
Annals of Internal Medicine|December 2, 2009
Aspirin withdrawal in acute peptic ulcer bleeding: are we harming patients?Alan N Barkun, Marc Bardou
Expert Opinion on Drug Safety|April 28, 2015
Safety of medication options for treating pediatric esophagitisMarc Bardou, Kyle J Fortinsky
Alimentary Pharmacology & Therapeutics|December 28, 2019
Editorial: how can we best promote the routine use of scores that are accurate at predicting outcomes in patients with upper gastrointestinal bleeding?Marc Bardou, Alan N Barkun
Pageof 15